Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma
type: MedicalStudy
description: A Randomized Phase III Trial Comparing the Combination of Fludarabine, BBR 2778 (Pixantrone) and Rituximab (FP-R) With the Combination of Fludarabine and Rituximab (F-R) in the Treatment of Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
status: WITHDRAWN
study design: INTERVENTIONAL
phase: PHASE3
start date: 2007-08
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00551239
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: CTI BioPharma
study subject: Leukemia
study subject: Lymphoma
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: WITHDRAWN
keywords: Leukemia
keywords: Lymphoma

AI Analytics
type: Organization